BIOMAT Database Logo BIOMAT Database Logo

Rituximab in refractory autoimmune hemolytic anemia in systemic lupus erythematosus. 2018

María Pavo-Blanco, and Marta Novella-Navarro, and Rafael Cáliz-Cáliz, and Miguel A Ferrer-González
Servicio de Reumatología, Complejo Hospitalario Universitario de Granada, Granada, España. Electronic address: mpb.mblanco@gmail.com.

UI MeSH Term Description Entries
D007155 Immunologic Factors Biologically active substances whose activities affect or play a role in the functioning of the immune system. Biological Response Modifier,Biomodulator,Immune Factor,Immunological Factor,Immunomodulator,Immunomodulators,Biological Response Modifiers,Biomodulators,Factors, Immunologic,Immune Factors,Immunological Factors,Modifiers, Biological Response,Response Modifiers, Biological,Factor, Immune,Factor, Immunological,Factors, Immune,Factors, Immunological,Modifier, Biological Response,Response Modifier, Biological
D008180 Lupus Erythematosus, Systemic A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys, and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow. Libman-Sacks Disease,Lupus Erythematosus Disseminatus,Systemic Lupus Erythematosus,Disease, Libman-Sacks,Libman Sacks Disease
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000069283 Rituximab A murine-derived monoclonal antibody and ANTINEOPLASTIC AGENT that binds specifically to the CD20 ANTIGEN and is used in the treatment of LEUKEMIA; LYMPHOMA and RHEUMATOID ARTHRITIS. CD20 Antibody, Rituximab,GP2013,IDEC-C2B8,IDEC-C2B8 Antibody,Mabthera,Rituxan,IDEC C2B8,IDEC C2B8 Antibody,Rituximab CD20 Antibody
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000744 Anemia, Hemolytic, Autoimmune Acquired hemolytic anemia due to the presence of AUTOANTIBODIES which agglutinate or lyse the patient's own RED BLOOD CELLS. Anemia, Hemolytic, Idiopathic Acquired,Autoimmune Haemolytic Anaemia,Autoimmune Hemolytic Anemia,Cold Agglutinin Disease,Hemolytic Anemia, Autoimmune,Acquired Autoimmune Hemolytic Anemia,Anemia, Hemolytic, Cold Antibody,Cold Antibody Disease,Cold Antibody Hemolytic Anemia,Idiopathic Autoimmune Hemolytic Anemia,Agglutinin Disease, Cold,Anaemia, Autoimmune Haemolytic,Anemia, Autoimmune Hemolytic,Autoimmune Haemolytic Anaemias,Autoimmune Hemolytic Anemias,Cold Agglutinin Diseases,Cold Antibody Diseases,Haemolytic Anaemia, Autoimmune

Related Publications

María Pavo-Blanco, and Marta Novella-Navarro, and Rafael Cáliz-Cáliz, and Miguel A Ferrer-González
Successful rituximab treatment of refractory hemophagocytic lymphohistiocytosis and autoimmune hemolytic anemia associated with systemic lupus erythematosus.
September 2014, Modern rheumatology,
María Pavo-Blanco, and Marta Novella-Navarro, and Rafael Cáliz-Cáliz, and Miguel A Ferrer-González
Successful treatment of systemic lupus erythematosus-related refractory autoimmune hemolytic anemia with ofatumumab.
December 2019, Lupus,
María Pavo-Blanco, and Marta Novella-Navarro, and Rafael Cáliz-Cáliz, and Miguel A Ferrer-González
Autoimmune hemolytic anemia in patients with systemic lupus erythematosus.
February 2000, The American journal of medicine,
María Pavo-Blanco, and Marta Novella-Navarro, and Rafael Cáliz-Cáliz, and Miguel A Ferrer-González
Refractory autoimmune hemolytic anemia in a systemic lupus erythematosus patient: A clinical case report.
March 2022, Clinical case reports,
María Pavo-Blanco, and Marta Novella-Navarro, and Rafael Cáliz-Cáliz, and Miguel A Ferrer-González
Rituximab in steroid refractory autoimmune hemolytic anemia.
June 2012, Indian journal of pediatrics,
María Pavo-Blanco, and Marta Novella-Navarro, and Rafael Cáliz-Cáliz, and Miguel A Ferrer-González
Autoimmune hemolytic anemia in systemic lupus erythematosus: association with thrombocytopenia.
December 2010, Clinical rheumatology,
María Pavo-Blanco, and Marta Novella-Navarro, and Rafael Cáliz-Cáliz, and Miguel A Ferrer-González
Rituximab for refractory childhood autoimmune hemolytic anemia.
November 2002, The Israel Medical Association journal : IMAJ,
María Pavo-Blanco, and Marta Novella-Navarro, and Rafael Cáliz-Cáliz, and Miguel A Ferrer-González
[Autoimmune hemolytic anemia as presentation form of systemic lupus erythematosus].
September 2003, Anales de medicina interna (Madrid, Spain : 1984),
María Pavo-Blanco, and Marta Novella-Navarro, and Rafael Cáliz-Cáliz, and Miguel A Ferrer-González
Danazol therapy in autoimmune hemolytic anemia associated with systemic lupus erythematosus.
February 1991, The Journal of rheumatology,
María Pavo-Blanco, and Marta Novella-Navarro, and Rafael Cáliz-Cáliz, and Miguel A Ferrer-González
Rituximab in patients with refractory autoimmune hemolytic anemia.
August 2011, Annals of hematology,
Copied contents to your clipboard!